Skip to the page

Data / Drug companies / Novadoz Pharmaceuticals LLC

Novadoz Pharmaceuticals LLC: 249 products in the FDA NDC directory, labeler code 72205

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Novadoz Pharmaceuticals LLC (labeler code 72205) lists 249 products in the FDA National Drug Code Directory, covering 93 finished drugs by generic name. By type: 249 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 11, 2026.

The request: Watch Novadoz Pharmaceuticals LLC (FDA labeler code 72205): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72205
Products in commercial distribution
249
Packages
480
Finished drugs by generic name
93
Prescription products
249
Over the counter products
0
Controlled substance products
Schedule II 9, Schedule III 7, Schedule IV 2, Schedule V 20
Flagged as original packager
229 of 229 products that carry the flag
Started marketing in the last 12 months
54
Earliest marketing start
November 22, 2017
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)249100%

Products by type

TypeProductsShare
Prescription drugs249100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Pregabalin1154
Perampanel76
Brivaracetam717
Doxepin hydrochloride745
Levetiracetam687
Chlorpromazine hydrochloride627
Dasatinib618
Haloperidol632
Deferasirox621
Lisdexamfetamine dimesylate616
Rosuvastatin calcium534
Bumetanide542
Lurasidone hydrochloride528
Sunitinib malate49
Nebivolol421
Dapagliflozin and metformin hydrochloride410
Atorvastatin calcium459
Oseltamivir phosphate437
Fluphenazine hydrochloride429
Tiagabine hydrochloride42
Eltrombopag olamine47
Droxidopa315
Losartan potassium343
Olmesartan medoxomil-hydrochlorothiazide34
Dabigatran etexilate317
Nilotinib310
Phenylephrine hydrochloride377
Abiraterone acetate322
Linagliptin and metformin hydrochloride32
Olmesartan medoxomil331
Prazosin hydrochloride335
Irbesartan327
Famotidine3138
Pomalidomide312
Erlotinib hydrochloride34
Tofacitinib323
Sacubitril and valsartan329
Vilazodone hydrochloride313
Aminocaproic acid323
Dofetilide312
Paclitaxel320
Tapentadol hydrochloride36
Capecitabine219
Silodosin215
Febuxostat222
Pirfenidone226
Darunavir214
Fosaprepitant210
Decitabine218
Thiotepa28
Dexrazoxane23
Sugammadex222
Dapagliflozin226
Arsenic trioxide221
Prucalopride218
Lacosamide257
Ivabradine212
Clobazam218
Ticagrelor232
Solifenacin succinate222
Tolvaptan29
Roflumilast217
Sirolimus122
Lofexidine hydrochloride14
Glycerol phenylbutyrate18
Clofarabine19
Fingolimod118
Albendazole110
Fluphenazine decanoate19
Carmustine113
Moxifloxacin hydrochloride tablets, 400 mg13
Sildenafil citrate124
Pyridostigmine bromide120
Acyclovir170
Bortezomib126
Toremifene citrate13
Nelarabine113
Isosulfan blue17
Trientine hydrochloride17
Valganciclovir hydrochloride111
Rufinamide112
Pimavanserin11
Ziprasidone mesylate19
Oxcarbazepine146
Vigabatrin118
Clopidogrel bisulfate131
Dapagliflozin and saxagliptin11
Rivaroxaban124
Glycopyrrolate164
Posaconazole129
Norepinephrine bitartrate125
Pantoprazole sodium154
Plerixafor113

Dosage forms

Dosage formProductsShare
Tablet, film coated8634.5%
Capsule4317.3%
Tablet4317.3%
Injection, solution114.4%
Injection104%
Injection, powder, lyophilized, for solution104%
Solution72.8%
Tablet, film coated, extended release72.8%
Tablet, chewable62.4%
Tablet, sugar coated41.6%
Suspension41.6%
Granule31.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Dasatinib72205-324TabletGeneric drugs (ANDA)September 11, 2026
Dasatinib72205-323TabletGeneric drugs (ANDA)September 11, 2026
Dasatinib72205-322TabletGeneric drugs (ANDA)September 11, 2026
Dasatinib72205-321TabletGeneric drugs (ANDA)September 11, 2026
Dasatinib72205-320TabletGeneric drugs (ANDA)September 11, 2026
Dasatinib72205-319TabletGeneric drugs (ANDA)September 11, 2026
Tapentadol Hydrochloride72205-371Tablet, film coatedGeneric drugs (ANDA)September 3, 2026
Tapentadol Hydrochloride72205-370Tablet, film coatedGeneric drugs (ANDA)September 3, 2026
Tapentadol Hydrochloride72205-369Tablet, film coatedGeneric drugs (ANDA)September 3, 2026
Pomalidomide72205-179CapsuleGeneric drugs (ANDA)September 2, 2026
Pomalidomide72205-178CapsuleGeneric drugs (ANDA)September 2, 2026
Pomalidomide72205-177CapsuleGeneric drugs (ANDA)September 2, 2026
Clofarabine72205-394InjectionGeneric drugs (ANDA)September 1, 2026
Fingolimod72205-227CapsuleGeneric drugs (ANDA)August 27, 2026
Sugammadex72205-479Injection, solutionGeneric drugs (ANDA)July 28, 2026
Sugammadex72205-478Injection, solutionGeneric drugs (ANDA)July 28, 2026
Tofacitinib72205-140Tablet, film coatedGeneric drugs (ANDA)June 3, 2026
Tofacitinib72205-139Tablet, film coatedGeneric drugs (ANDA)June 3, 2026
Tofacitinib72205-121SolutionGeneric drugs (ANDA)June 3, 2026
Oxcarbazepine72205-354SuspensionGeneric drugs (ANDA)May 29, 2026
Glycerol phenylbutyrate72205-331LiquidGeneric drugs (ANDA)April 15, 2026
Dapagliflozin and saxagliptin72205-438Tablet, film coatedGeneric drugs (ANDA)April 6, 2026
Dapagliflozin and metformin hydrochloride72205-437Tablet, film coated, extended releaseGeneric drugs (ANDA)April 6, 2026
Dapagliflozin and metformin hydrochloride72205-436Tablet, film coated, extended releaseGeneric drugs (ANDA)April 6, 2026
Dapagliflozin and metformin hydrochloride72205-435Tablet, film coated, extended releaseGeneric drugs (ANDA)April 6, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.